Valuation for CASI Pharmaceuticals Inc (id:5858 CASI)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -1.88 |
|
|
| Forward P/E | -1.78 |
|
|
| Price to sales | 2.54 |
|
|
| Price to book | 2.10 |
|
|
| Enterprise to revenue | 3.37 |
|
|
| Enterprise to ebitda | -3.37 |
|
|